Abstract:Abstract Building an accurate disease risk prediction model is an essential step in the modern quest for precision medicine. While high-dimensional genomic data provides valuable data resources for the investigations of disease risk, their huge amount of noise and complex relationships between predictors and outcomes have brought tremendous analytical challenges. Deep learning model is the state-of-the-art methods for many prediction tasks, and it is a promising framework for the analysis of genomic data. However, deep learning models generally suffer from the curse of dimensionality and the lack of biological interpretability, both of which have greatly limited their applications. In this work, we have developed a deep neural network (DNN) based prediction modeling framework. We first proposed a group-wise feature importance score for feature selection, where genes harboring genetic variants with both linear and non-linear effects are efficiently detected. We then designed an explainable transfer-learning based DNN method, which can directly incorporate information from feature selection and accurately capture complex predictive effects. The proposed DNN-framework is biologically interpretable, as it is built based on the selected predictive genes. It is also computationally efficient and can be applied to genome-wide data. Through extensive simulations and real data analyses, we have demonstrated that our proposed method can not only efficiently detect predictive features, but also accurately predict disease risk, as compared to many existing methods. Author summary Accurate disease risk prediction is an essential step towards precision medicine. Deep learning models have achieved the state-of-the-art performance for many prediction tasks. However, they generally suffer from the curse of dimensionality and lack of biological interpretability, both of which have greatly limited their applications to the prediction analysis of whole-genome sequencing data. We present here an explainable deep transfer learning model for the analysis of high-dimensional genomic data. Our proposed method can detect predictive genes that harbor genetic variants with both linear and non-linear effects via the proposed group-wise feature importance score. It can also efficiently and accurately model disease risk based on the detected predictive genes using the proposed transfer-learning based network architecture. Our proposed method is built at the gene level, and thus is much more biologically interpretable. It is also computationally efficiently and can be applied to whole-genome sequencing data that have millions of potential predictors. Through both simulation studies and the analysis of whole-genome sequencing data obtained from the Alzheimer’s Disease Neuroimaging Initiative, we have demonstrated that our method can efficiently detect predictive genes and it has better prediction performance than many existing methods.

Explainable models using transcription factor binding and epigenome patterns at promoters reveal disease-associated genes and their regulators in the context of cell-types

Understanding Variation in Transcription Factor Binding by Modeling Transcription Factor Genome-Epigenome Interactions.

Prediction of Transcription Factors Binding Events Based on Epigenetic Modifications in Different Human Cells.

Systematic Localization of Common Disease-Associated Variation in Regulatory DNA

Sequence-to-expression approach to identify etiological non-coding DNA variations in P53 and cMYC-driven diseases

A graphical model approach visualizes regulatory relationships between genome-wide transcription factor binding profiles

Prediction of the cell-type-specific transcription of non-coding RNAs from genome sequences via machine learning

Comprehensive network modeling approaches unravel dynamic enhancer-promoter interactions across neural differentiation

Unveiling new disease, pathway, and gene associations via multi-scale neural networks

Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics

Predicting the effect of CRISPR-Cas9-based epigenome editing

Enhancing patient stratification and interpretability through class-contrastive and feature attribution techniques

Specifying cellular context of transcription factor regulons for exploring context-specific gene regulation programs

Explainable deep transfer learning model for disease risk prediction using high-dimensional genomic data

Genomic annotation of disease-associated variants reveals shared functional contexts

Network Analysis of Enhancer-Promoter Interactions Highlights Cell-Type-Specific Mechanisms of Transcriptional Regulation Variation

Predicting the DNA binding specificity of mutated transcription factors using family-level biophysically interpretable machine learning

Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters

Transcriptome Complexity Disentangled: A Regulatory Molecules Approach

The Gene Expression Landscape of Disease Genes

Combining exome and gene expression datasets in one graphical model of disease to empower the discovery of disease mechanisms